IPOs

Capital hike, asset sales to fill gap at Monte Paschi -chairman

VIENNA, Dec 21 - Italian lender Monte dei Paschi di Siena expects to complete its planned capital increase by July and can use divestments to help plug a hole in its balance sheet, Chairman Alessandro Profumo told an Austrian newspaper.

UPDATE 2-U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks

Dec 19 - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Solvadi from Gilead Sciences.

Regulatory News, 20 Dec 2014

DIARY- Top Economic Events to Dec 25

** This Diary is filed daily ** ----------------------------------------------------------- TOP ECONOMIC EVENTS

20 Dec 2014

URGENT-Legg Mason board OKs new share purchases by top holder Trian

BOSTON, Dec 19 - Baltimore asset manager Legg Mason Inc's board has approved additional future share purchases by its top investor, Trian Fund Management, according to company filing on Friday.

Regulatory News, 20 Dec 2014

Cirque du Soleil hires Goldman Sachs to look for partner

Dec 19 - Canadian performance company Cirque du Soleil has hired investment bank Goldman Sachs Group Inc to help in its previously disclosed effort to find a strategic partner, a spokeswoman for the company said on Friday.

Private Capital 20 Dec 2014

UPDATE 1-U.S. FDA approves AbbVie all-oral hepatitis C treatment

Dec 19 - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, providing the first competition for Gilead Sciences huge selling and expensive medicine for the liver-destroying virus.

Regulatory News, 20 Dec 2014

U.S. FDA approves AbbVie all-oral hepatitis C treatment

Dec 19 - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, providing the first competition for Gilead Sciences huge selling and expensive medicine for the liver-destroying virus.

Regulatory News 20 Dec 2014

BRIEF-Bank of Canada term repo operation results

Dec 19 - The Bank of Canada said its C$700 million 24-day term repo for balance sheet management had an average yield of 1.050 percent, a high yield of 1.050 percent, and a low yield of 1.050 percent.

19 Dec 2014

Emerging markets sell-off may provide opportunity

NEW YORK, Dec 19 (IFR) - Emerging market bonds fell victim to indiscriminate selling this week, as weak oil prices and low liquidity sent investors running for cover ahead of potential redemptions.

19 Dec 2014

JGBs mostly firm, yields out to four years below zero

TOKYO, Dec 19 - Japanese government bond prices held mostly firm on Friday with two-year yield hitting a record low and yields up to four years staying below zero on expectations of a bond shortage next week, ahead of a large redemption.

Japan 19 Dec 2014